Addressing the Challenges of Progressive Multiple Sclerosis: Cases in Progressive MS

Jiwon Oh, MD, PhD, FRCPC
James M. Stankiewicz, MD
Released: August 30, 2019 Expiration: No longer available for credit

Related Content

Calli Cook, DNP, APRN, FNP-C, FAANP and Lisa Aquillano, PharmD, BCPS, MSCS: updated McDonald diagnostic and differential diagnosis criteria, MS phenotypes, and MS signs and symptoms.

person default Lisa Aquillano, PharmD, BCPS, MSCS person default Calli Cook, DNP, APRN, FNP-C, FAANP Nurse Practitioners: 0.67 AANP contact hours Released: August 1, 2020 Expired: August 1, 2021

Calli Cook, DNP, APRN, FNP-C, FAANP and Lisa Aquillano, PharmD, BCPS, MSCS: Important considerations when starting or stopping disease modifying therapies in patients with MS are discussed.

person default Lisa Aquillano, PharmD, BCPS, MSCS person default Calli Cook, DNP, APRN, FNP-C, FAANP Nurse Practitioners: 0.67 AANP contact hours Released: August 1, 2020 Expired: August 1, 2021

Calli Cook, DNP, APRN, FNP-C, FAANP and Lisa Aquillano, PharmD, BCPS, MSCS: Important considerations when starting or stopping disease modifying therapies in patients with MS.

person default Lisa Aquillano, PharmD, BCPS, MSCS person default Calli Cook, DNP, APRN, FNP-C, FAANP Nurse Practitioners: 0.5 AANP contact hours Released: August 1, 2020 Expired: August 1, 2021

Concise CCO activity on selecting second-generation antipsychotics for treatment augmentation in patients with MDD and managing adverse events

Rakesh Jain, MD, MPH Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 7, 2020 Expired: May 6, 2021
Provided by
Purdue University Logo

Accreditation: Dawn Sinclair, Purdue University sinclaid@purdue.edu
Certificates/Credits: Heather Holley, Purdue University hholley@purdue.edu

This activity is supported by an educational grant from
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue